secwatch.observer — SEC 8-K summary
======================================

Issuer:     Orthofix Medical Inc. (OFIX)
CIK:        0000884624
Form:       8-K
Filed at:   2023-01-09T23:59:59+00:00
Accession:  0000950170-23-000431
Event type: earnings
Sentiment:  neutral
Materiality: 0.60
Item codes: 2.02, 9.01
LLM model:  deepseek-v4-flash:cloud@v2

Orthofix reports Q4 net sales $122.2M (-2% YoY); SeaSpine Q4 $63.2-63.7M (+13%+); merger closed Jan 5
--------------------------------------------------------------------------------

- Orthofix Q4 net sales $122.2M, down ~2% YoY; constant currency flat; Bone Growth Therapies up ~3%.
- SeaSpine Q4 net sales $63.2-63.7M, up >13% YoY; U.S. Spinal Implants +23%, U.S. Orthobiologics +19%.
- Full-year: Orthofix $460.7M (-0.8% as reported); SeaSpine ~$237.6M (+24% YoY).
- Cash: Orthofix $51M; SeaSpine $29M; Orthofix borrowed $30M on revolver for merger expenses.
- Merger of equals completed Jan 5; SeaSpine shareholders receiving 0.4163 OFIX shares per share.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/884624/000095017023000431/0000950170-23-000431-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/884624/000095017023000431/ofix-20230109.htm
  HTML page:      https://secwatch.observer/filing/0000950170-23-000431

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer